Access cutting-edge migraine treatment through this clinical trial at a research site in Huntsville. Study-provided care at no cost to qualified participants.
Access migraine specialists in Huntsville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Sponsor: Eli Lilly and Company
Check if you qualify for this migraine clinical trial in Huntsville, AL
If you're searching for migraine treatment options in Huntsville, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Huntsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.